iOrgan Bio
Overview
The Right Cells.Consistently.At Scale.. iOrganBio's (iOB) CellForge™ Platform brings precision engineering to the creation of human cells and organoids with unmatched reproducible, scalable, and AI-guided cell manufacturing for in vitro modeling and cell therapies.
Funding and backers
Backers
1
SOSV
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Designer cell therapies for pets first and their people next.
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform…
Organ-on-a-Chip made easy for precise experiments — VitroFlow is our versatile organ-on-a-chip platform for in vitro modeling of human…
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
Building the next generation of cell therapies. Cell therapies face key challenges that limit their efficacy and accessibility:.
Standardize, streamline, and scale your cell culture protocols, starting with iPSCs. Elevate your science and industrialize your cell…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
777 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely